PSA-nadir at 1 year as a sound contemporary prognostic factor for low-dose-rate iodine-125 seeds brachytherapy
Author:
Publisher
Springer Science and Business Media LLC
Subject
Urology
Link
http://link.springer.com/content/pdf/10.1007/s00345-013-1148-6.pdf
Reference21 articles.
1. Merrick GS, Butler WM, Dorsey AT, Galbreath RW, Blatt H, Lief JH (2000) Rectal function following prostate brachytherapy. Int J Radiat Oncol Biol Phys 48(3):667–674
2. Sylvester JE, Grimm PD, Wong J, Galbreath RW, Merrick G, Blasko JC (2011) Fifteen-year biochemical relapse-free survival, cause-specific survival, and overall survival following I (125) prostate brachytherapy in clinically localized prostate cancer: Seattle experience. Int J Radiat Oncol Biol Phys 81(2):376–381
3. Vigneri P, Herati AS, Potters L (2010) The second decade of prostate brachytherapy: evidence and cost based outcomes. Urol Oncol 28(1):86–90
4. Roach M III, Hanks G, Thames H Jr, Schellhammer P, Shipley WU, Sokol GH et al (2006) Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG–ASTRO phoenix consensus conference. Int J Radiat Oncol Biol Phys 65(4):965–974
5. Rivard MJ, Butler WM, Devlin PM, Hayes JK Jr, Hearn RA, Lief EP, Meigooni AS, Merrick GS, Williamson JF (2007) American Brachytherapy Society recommends no change for prostate permanent implant dose prescriptions using iodine-125 or palladium-103. Brachytherapy 6(1):34–37
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Biochemical outcomes and toxicities in young men with prostate cancer after permanent iodine-125 seed implantation: Prospective cohort study in 6662 patients;Brachytherapy;2023-05
2. Patient age as a predictive factor in biochemical recurrence following brachytherapy: Oncological outcomes at a single center;Prostate International;2022-12
3. Biochemical outcomes and predictive factors by risk group after permanent iodine-125 seed implantation: Prospective cohort study in 2,316 patients;Brachytherapy;2019-09
4. Selection of patients who would not require long-term prostate-specific antigen monitoring after low-dose-rate brachytherapy;Brachytherapy;2018-11
5. Manual vs. automated implantation of seeds in prostate brachytherapy: Oncologic results from a single-center study;Brachytherapy;2018-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3